Literature DB >> 18585693

Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice.

Marie-Caroline Cotel1, Thomas A Bayer, Oliver Wirths.   

Abstract

Loss of neurons in the hippocampus and other brain regions is, besides the occurrence of plaques and tangles, a neuropathological feature of Alzheimer's disease (AD). In recent years a plethora of transgenic mouse models overexpressing mutant amyloid precursor protein (APP) has been developed, which represent valuable research tools. Whereas extracellular plaque pathology is a common feature of these models, neuronal loss is a rather rare characteristic. In the present study, we quantified the number of neurons in the dentate gyrus granule layer (GCL) in 2- and 12-month-old APP/PS1KI mice, a mouse model that has been previously shown to have significant loss of neurons in the CA1 layer of the hippocampus. Stereological analysis revealed a strongly significant decrease of GCLs in aged APP/PS1KI mice, compared to age-matched PS1KI control animals (-44%), however, the volume of the GCL was not different.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585693     DOI: 10.1016/j.brainres.2008.05.052

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study.

Authors:  Po H Lu; Paul M Thompson; Alex Leow; Grace J Lee; Agatha Lee; Igor Yanovsky; Neelroop Parikshak; Theresa Khoo; Stephanie Wu; Daniel Geschwind; George Bartzokis
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.

Authors:  Hisaaki Takahashi; Ivona Brasnjevic; Bart P F Rutten; Nicolien Van Der Kolk; Daniel P Perl; Constantin Bouras; Harry W M Steinbusch; Christoph Schmitz; Patrick R Hof; Dara L Dickstein
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

Review 4.  Altered neurogenesis in mouse models of Alzheimer disease.

Authors:  Oliver Wirths
Journal:  Neurogenesis (Austin)       Date:  2017-05-09

5.  REGION-SPECIFIC NEURON AND SYNAPSE LOSS IN THE HIPPOCAMPUS OF APPSL/PS1 KNOCK-IN MICE.

Authors:  Ivona Brasnjevic; Roy Lardenoije; Christoph Schmitz; Nicolien Van Der Kolk; Dara L Dickstein; Hisaaki Takahashi; Patrick R Hof; Harry W M Steinbusch; Bart P F Rutten
Journal:  Transl Neurosci       Date:  2013-03-01       Impact factor: 1.757

Review 6.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

Review 7.  Basic quantitative morphological methods applied to the central nervous system.

Authors:  Lutz Slomianka
Journal:  J Comp Neurol       Date:  2020-08-01       Impact factor: 3.215

8.  Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer's Disease.

Authors:  Naomi K Giesers; Oliver Wirths
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

9.  Modifications of hippocampal circuits and early disruption of adult neurogenesis in the tg2576 mouse model of Alzheimer's disease.

Authors:  Alice Krezymon; Kevin Richetin; Hélène Halley; Laurent Roybon; Jean-Michel Lassalle; Bernard Francès; Laure Verret; Claire Rampon
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model.

Authors:  M Hüttenrauch; A Brauß; A Kurdakova; H Borgers; F Klinker; D Liebetanz; G Salinas-Riester; J Wiltfang; H W Klafki; O Wirths
Journal:  Transl Psychiatry       Date:  2016-05-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.